When it comes to diagnosing and treating obstructive sleep apnea (OSA), precision is everything. Among the many tools introduced over the years, Drug-Induced Sleep Endoscopy (DISE) stands out for its ability to visually assess the upper airway during sleep-like conditions. But with its growing popularity comes a fair share of skepticism—Is DISE truly insightful or potentially misleading?
This blog dives into that debate, drawing insights from Dr. Srinivas Kishore’s comprehensive presentation on the clinical utility, limitations, and evolving role of DISE in managing OSA. From its potential to guide personalized surgical plans to the limitations surrounding sedation depth and interobserver variability, every angle is explored.
👉 Scroll down to view the full slide presentation and decide for yourself—is DISE a diagnostic game-changer or a costly overreach?